Wisconsin gets $3.4 million under Mylan settlement
Wisconsin will receive $3.4 million under a settlement reached between states and Mylan over allegations that the drug manufacturer knowingly underpaid rebates to the Medicaid program for its device that counteracts allergic reactions, according to a Wednesday statement.
To access this content, you must purchase a Premium membership, or log in if you are a member.
